VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -44.0% | 61,464 | -5.2% | 0.00% | -50.0% |
| Q2 2022 | $25,000 | +56.2% | 64,838 | +163.6% | 0.00% | +100.0% |
| Q1 2022 | $16,000 | -91.1% | 24,601 | -86.0% | 0.00% | -94.4% |
| Q4 2021 | $179,000 | +18.5% | 175,278 | +61.8% | 0.02% | +38.5% |
| Q3 2021 | $151,000 | +62.4% | 108,319 | +696.6% | 0.01% | +85.7% |
| Q1 2021 | $93,000 | – | 13,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 450,000 | $1,580,000 | 3.15% |
| DSC Advisors, L.P. | 1,100,000 | $3,861,000 | 2.79% |
| CM Management, LLC | 143,750 | $505,000 | 0.36% |
| Perceptive Advisors | 11,547,908 | $40,534,000 | 0.26% |
| DELTEC ASSET MANAGEMENT LLC | 386,491 | $1,357,000 | 0.19% |
| Tibra Equities Europe Ltd | 91,000 | $319,000 | 0.10% |
| 683 Capital Management, LLC | 733,683 | $2,575,000 | 0.09% |
| Banque Cantonale Vaudoise | 200,000 | $702,000 | 0.03% |
| Platform Technology Partners | 15,832 | $56,000 | 0.02% |
| Tekla Capital Management LLC | 135,395 | $475,000 | 0.02% |